YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)

Pharmaceutical Whistleblower


AddThis Social Bookmark Button

Pharmaceutical Whistleblower

In recent years many pharmaceutical employees have come forward to report fraudulent billing, illegal marketing techniques and undisclosed drug side effects. These courageous people known as whistle blowers have helped the federal government recover millions of dollars that were obtained illegally by the pharmaceutical companies. More importantly whistle blowers have helped save the lives of thousands of prescription drug users that were previously unaware of their medication's side effects.

Recently, a former Pfizer Microbiologist David Franklin blew the whistle on Pfizer's Warner-Lambert unit over promoting the epilepsy drug Neurontin for off-label uses. Franklin’s testimony led to the Government's recovery of over $400 million dollars from Pfizer. Franklin's reward will be about $26 million.

Franklin sued the company in 1996 under the False Claims Act. The False Claims Act is a US law that encourages employees to report illegal activities at their companies. The law was passed in 1863 to crack down on war-profiteering during the Civil War. It allows individuals to bring lawsuits on behalf of the federal Government and receive part of any settlement or judgment.

Last year, the Justice Department recovered $2.1 billion under the False Claims Act, up from $1.1 billion the previous year. Franklin's award is far from the largest. In 2001 Douglas Durand, a former vice-president of sales at TAP Pharmaceuticals, received $77 million for blowing the whistle on his employer.

If you are a current or former pharmaceutical company employee and have information on any illegal activities, please fill out the form at the right for a free case evaluation by a qualified attorney.
Pharmaceutical WhistleblowerRSS Feed

Ketek case keeps glare on reform

Feb 14, 2007 | The Star Ledger
The Food and Drug Administration's missteps in approving the controversial antibiotic Ketek were cited at a congressional hearing yesterday as further evidence of the need for major drug safety reform. FDA whistle-blowers, medical experts and members of Congress said the FDA in 2004 approved Ketek, since linked to liver failures, despite serious safety warnings from scientific reviewers and evidence of fraudulent data. They told the House Energy and Commerce subcommittee on oversight and...

Ex-J&J officer files lawsuit as whistle-blower

Dec 15, 2006 | Star Ledger
The former chief medical officer for a unit of Johnson & Johnson has filed a whistle-blower lawsuit against the company, claiming he was fired for seeking product recalls of several faulty medical devices. Joel Lippman said he was terminated from his post at Ethicon in May, after working at the subsidiary for almost six years. Before that, Lippman, 52, of Warren, helped oversee clinical trials for a decade at another J&J unit, Ortho-McNeil Pharmaceuticals.  Lippman claims he...

Chief Medical Officer Blows Whistle On Johnson & Johnson

Dec 13, 2006 | www.courthousenews.com
Johnson & Johnson subsidiary Ethicon fired its chief medical officer because of his insistence that unsafe medical products be recalled, Dr. Joel Lippman claims in Middlesex County Court. Lippman claims that during 15 years in high-ranking medical positions at Ethicon and Ortho McNeil, another J&J subsidiary, Johnson & Johnson repeatedly released or refused to recall dangerous products to which he objected, including the Ortho-Evra birth control patch and Intergel. Both products...

Lawmaker Alleges FDA, Merck Collaborated

Jul 19, 2006 | AP
A federal health official worked with drug maker Merck to discredit a government whistleblower who publicized safety risks associated with the painkiller Vioxx, a lawmaker alleged Wednesday in seeking an investigation. Sen. Charles Grassley, R-Iowa, asked the inspector general at the Health and Human Services Department to probe whether the Food and Drug Administration and Merck acted in concert to call into question the safety findings made by Dr. David Graham, an FDA drug safety official. ...

Judge orders FDA whistleblower to testify

Mar 15, 2006 | AP
The Food and Drug Administration whistleblower who has criticized the agency's handling of Vioxx will be deposed, a judge ruled, offering evidence that could aid thousands of lawsuits over the withdrawn pain killer. A federal judge refused to grant a government motion to quash plaintiffs' lawyers subpoena of drug reviewer Dr. David Graham, who testified at a 2004 Congressional hearing that the Merck & Co. drug caused as many as 160,000 heart attacks and strokes. Graham questioned the...

More Pharmaceutical Whistleblower News

Pharmaceutical Whistleblower
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Name of pharmaceutical company:

General description of allegation:

Was described allegation a Medicare or Medicaid fraud?


Year in which allegations started:

Year in which allegations ended:

Basis of knowlege:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | ReNu with MoistureLoc | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2008 YourLawyer.com. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News